A Four-Year Report on Renal Outcomes Following the Elective Withdrawal of Long-Term Renin-Angiotensin-Aldosterone Blockade in a Cohort of Patients With Otherwise Inexplicable New-Onset and Progressive Acute Kidney Injury

Background Renin-angiotensin-aldosterone (RAAS) blockade is acclaimed, by consensus, to be renoprotective in both diabetic and non-diabetic chronic kidney disease (CKD). Contradictory reports exist regarding renal and cardiovascular outcomes after stopping RAAS blockade in advanced CKD. A few prospe...

Descripción completa

Detalles Bibliográficos
Autor principal: Onuigbo, Macaulay A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701493/
https://www.ncbi.nlm.nih.gov/pubmed/36447726
http://dx.doi.org/10.7759/cureus.30794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701493/
https://www.ncbi.nlm.nih.gov/pubmed/36447726
http://dx.doi.org/10.7759/cureus.30794

Ejemplares similares